Hepatitis C - Injection of blood products Factor
Last reviewed for CCPS 30 April 1997.
Investigative Documents
Claimant Report - Transfusion of Blood or Blood Products [CR9012]
Medical Report - Blood Transfusion and Injection of Blood Products - Hepatitis [MR9051]
Preliminary questions [10231]
there is some evidence that a blood products injection may be a factor in the development of the condition under consideration.7025 the veteran has had a blood product injection at some time.
10250 the veteran had a blood products injection more than 2 weeks before the clinical onset of hepatitis C.
the blood products injection more than 2 weeks before the clinical onset of hepatitis C was screened for hepatitis C.10253 — the veteran has established the causal connection between the blood product injection and VEA service for the clinical onset of hepatitis C.
10254 — the veteran has established the causal connection between the blood product injection and operational service for the clinical onset of hepatitis C.
or
10255 — the veteran has established the causal connection between the blood product injection and eligible service for the clinical onset of hepatitis C.
Clinical onset and operational service [10254]
the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C was given on operational service. the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C was given on operational service, as a causal result of operational service. the receipt of the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C, on operational service, was due to the veteran's serious default, wilful act or serious breach of discipline.or
the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C was given for treatment of an illness or injury which is identifiable.7029 — the identified illness or injury for which the blood product injection was given is causally related to operational service.
Clinical onset and eligible service [10255]
the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C was given on eligible service. the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C was given on eligible service, as a causal result of eligible service duties. the receipt of the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C, on eligible service, was due to the veteran's serious default, wilful act or serious breach of discipline.or
the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C was given for treatment of an illness or injury which is identifiable.10256 — the identified illness or injury for which the blood product injection was given is causally related to eligible service.